226 related articles for article (PubMed ID: 31109348)
1. Barriers to the National Onchocerciasis Control Programme at operational level in Cameroon: a qualitative assessment of stakeholders' views.
Dissak-Delon FN; Kamga GR; Humblet PC; Robert A; Souopgui J; Kamgno J; Ghogomu SM; Godin I
Parasit Vectors; 2019 May; 12(1):246. PubMed ID: 31109348
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting community participation in the CDTI program in Morogoro, Tanzania.
York KJ; Kabole I; Mrisho M; Berry DM; Schmidt E
J Nurs Scholarsh; 2015 Jan; 47(1):96-104. PubMed ID: 25565278
[TBL] [Abstract][Full Text] [Related]
3. Programmatic factors associated with the limited impact of Community-Directed Treatment with Ivermectin to control Onchocerciasis in three drainage basins of South West Cameroon.
Duamor CT; Datchoua-Poutcheu FR; Chounna Ndongmo WP; Yoah AT; Njukang E; Kah E; Maingeh MS; Kengne-Ouaffo JA; Tayong DB; Enyong PA; Wanji S
PLoS Negl Trop Dis; 2017 Nov; 11(11):e0005966. PubMed ID: 29155826
[TBL] [Abstract][Full Text] [Related]
4. Audit of the community-directed treatment with ivermectin (CDTI) for onchocerciasis and factors associated with adherence in three regions of Cameroon.
Kamga GR; Dissak-Delon FN; Nana-Djeunga HC; Biholong BD; Ghogomu SM; Souopgui J; Kamgno J; Robert A
Parasit Vectors; 2018 Jun; 11(1):356. PubMed ID: 29921312
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of onchocerciasis control in the Upper Denkyira East municipal in the forest area of Ghana: Responses of participants and distributors to the CDTI programme.
Agyemang ANO; Badu K; Baffour-Awuah S; Owusu-Dabo E; Biritwum NK; Garms R; Kruppa TF
Acta Trop; 2018 Sep; 185():357-362. PubMed ID: 29932933
[TBL] [Abstract][Full Text] [Related]
6. Contribution and performance of female Community-Directed Distributors in the treatment of onchocerciasis with Ivermectin in Sub-Saharan Africa: a systematic review.
Vouking MZ; Tamo VC; Tadenfok CN
Pan Afr Med J; 2015; 20():188. PubMed ID: 26430485
[TBL] [Abstract][Full Text] [Related]
7. Implementing community-directed treatment with ivermectin for the control of onchocerciasis in Uganda (1997-2000): an evaluation.
Katabarwa MN; Habomugisha P; Richards FO
Ann Trop Med Parasitol; 2002 Jan; 96(1):61-73. PubMed ID: 11998803
[TBL] [Abstract][Full Text] [Related]
8. Additional health and development activities for community-directed distributors of ivermectin: threat or opportunity for onchocerciasis control?
Okeibunor JC; Ogungbemi MK; Sama M; Gbeleou SC; Oyene U; Remme JH
Trop Med Int Health; 2004 Aug; 9(8):887-96. PubMed ID: 15303994
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with coverage in community-directed treatment with ivermectin for onchocerciasis control in Oyo State, Nigeria.
Brieger WR; Otusanya SA; Oke GA; Oshiname FO; Adeniyi JD
Trop Med Int Health; 2002 Jan; 7(1):11-8. PubMed ID: 11851950
[TBL] [Abstract][Full Text] [Related]
10. A multi-centre study of community-directed ivermectin distributors' (CDDs') involvement in other healthcare and development programme activities in Cameroon, Togo, Sudan, Nigeria and Uganda.
Sama MT; Homeida M; Ngang P; Liese BH; Amazigo U; Seketeli A
Trop Doct; 2003 Oct; 33(4):237-41. PubMed ID: 14620432
[TBL] [Abstract][Full Text] [Related]
11. Factors Associated with Ivermectin Non-Compliance and Its Potential Role in Sustaining Onchocerca volvulus Transmission in the West Region of Cameroon.
Senyonjo L; Oye J; Bakajika D; Biholong B; Tekle A; Boakye D; Schmidt E; Elhassan E
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004905. PubMed ID: 27529622
[TBL] [Abstract][Full Text] [Related]
12. Adherence to ivermectin is more associated with perceptions of community directed treatment with ivermectin organization than with onchocerciasis beliefs.
Dissak-Delon FN; Kamga GR; Humblet PC; Robert A; Souopgui J; Kamgno J; Essi MJ; Ghogomu SM; Godin I
PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005849. PubMed ID: 28806785
[TBL] [Abstract][Full Text] [Related]
13. Gender issues in the community-directed treatment with ivermectin (CDTI) of the African Programme for Onchocerciasis Control (APOC).
Clemmons L; Amazigo UV; Bissek AC; Noma M; Oyene U; Ekpo U; Msuya-Mpanju J; Katenga S; Sékétéli A
Ann Trop Med Parasitol; 2002 Mar; 96 Suppl 1():S59-74. PubMed ID: 12081252
[TBL] [Abstract][Full Text] [Related]
14. Community-directed health (CDH) workers enhance the performance and sustainability of CDH programmes: experience from ivermectin distribution in Uganda.
Katabarwa MN; Richards FO
Ann Trop Med Parasitol; 2001 Apr; 95(3):275-86. PubMed ID: 11339887
[TBL] [Abstract][Full Text] [Related]
15. Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results.
Tekle AH; Zouré HG; Noma M; Boussinesq M; Coffeng LE; Stolk WA; Remme JH
Infect Dis Poverty; 2016 Jun; 5(1):66. PubMed ID: 27349645
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation on implementation of the African programme for onchocerciasis control in Nigeria].
Xie Z; Nsofor I; Tolhurst R
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Jun; 44(3):403-6. PubMed ID: 22692311
[TBL] [Abstract][Full Text] [Related]
17. Predictors for compliance with community directed ivermectin treatment in Bushenyi district of Uganda: qualitative results.
Nuwaha F; Okware J; Ndyomugyenyi R
East Afr Med J; 2004 Feb; 81(2):92-6. PubMed ID: 15125093
[TBL] [Abstract][Full Text] [Related]
18. Implementation of test-and-treat with doxycycline and temephos ground larviciding as alternative strategies for accelerating onchocerciasis elimination in an area of loiasis co-endemicity: the COUNTDOWN consortium multi-disciplinary study protocol.
Wanji S; Nji TM; Hamill L; Dean L; Ozano K; Njouendou AJ; Abong RA; Obie ED; Amuam A; Ekanya R; Ndongmo WPC; Ndzeshang BL; Fung EG; Nnamdi DB; Nkimbeng DA; Teghen S; Kah E; Piotrowski H; Forrer A; Khan JAM; Woode ME; Niessen L; Watson V; Njoumemi Z; Murdoch ME; Thomson R; Theobald S; Enyong P; Turner JD; Taylor MJ
Parasit Vectors; 2019 Dec; 12(1):574. PubMed ID: 31801631
[TBL] [Abstract][Full Text] [Related]
19. The selection and validation of indicators for monitoring progress towards self-sustainment in community-directed, ivermectin-treatment programmes for onchocerciasis control in Uganda.
Katabarwa MN; Mutabazi D
Ann Trop Med Parasitol; 1998 Dec; 92(8):859-68. PubMed ID: 10396346
[TBL] [Abstract][Full Text] [Related]
20. [Systematic review on the contribution of women community distributors in the fight against onchocerciasis sub-Saharan Africa].
Vouking MZ; Tadenfok CN; Evina CD; Nsangou M; Bonono CR; Yondo D
Pan Afr Med J; 2014; 19():318. PubMed ID: 25883745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
